Mergers & Acquisitions
No reason was given for the request of voluntary dismissal.
The transaction is valued at $132 million and is expected to close during the second quarter of this year.
CFOs want to find the right acquisition target that fits the culture of the organization, says Vin Phan of BDO.
BioPlus provides a range of specialty pharmacy services for patients living with complex and chronic conditions.
Paid annual memberships give access to on-demand and virtual care services.
A Nasdaq delisting follows reports that the FTC was unlikely to challenge the deal,
Elevance expects the deal will help it fill the specialty drug needs of clients by using a whole-health focus.
The organizations say the acquisition will benefit patients' long-term health by reducing care costs and improving outcomes.
The combination builds on a collaboration through joint ownership of Healthy Blue, which serves Medicaid and Medicare Dual Eligible members.
There were seven announced transactions in Q4, and four of them met Kaufman Hall's definition of 'mega merger.